Abatacept, a biologic used to treat rheumatoid arthritis (RA), staved off the disease in people who were at high risk for the condition, according to results from a randomized clinical trial that involved 213 participants from the Netherlands and the UK.
No takes yet. Share an insight, caveat, or question.
Emily Harris (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: